Monique B Nilsson - JoVE Visualize

Showing results (11-20 of 42) with videos related to

Pageof 5

Sort By:

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2026

Adaptive feedback signaling via the FAK/SRC pathway promotes KRAS G12C inhibitor resistanceHibiki Udagawa, Yuji Shibata, Monique B Nilsson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014

VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.

The Journal of Biological Chemistry|August 25, 2007

Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanismMonique B Nilsson, Guillermo Armaiz-Pena, Rie Takahashi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023

IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015

KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.

The Journal of Clinical Investigation|December 9, 2025

Osimertinib activates a TGFβ2-dependent secretory program that drives lung adenocarcinoma progressionMadhurima Ghosh, Chao Wu, Abhishek Kumar, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.

The Journal of Clinical Investigation|March 26, 2011

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinomaTina Cascone, Matthew H Herynk, Li Xu, et al.

Cancer Research|July 5, 2011

Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent PhenotypeMonique B Nilsson, Jacqulyne Robichaux, Matthew H Herynk, et al.

Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:

Pageof 5

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2026

Adaptive feedback signaling via the FAK/SRC pathway promotes KRAS G12C inhibitor resistanceHibiki Udagawa, Yuji Shibata, Monique B Nilsson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014

VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.

The Journal of Biological Chemistry|August 25, 2007

Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanismMonique B Nilsson, Guillermo Armaiz-Pena, Rie Takahashi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023

IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015

KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.

The Journal of Clinical Investigation|December 9, 2025

Osimertinib activates a TGFβ2-dependent secretory program that drives lung adenocarcinoma progressionMadhurima Ghosh, Chao Wu, Abhishek Kumar, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.

The Journal of Clinical Investigation|March 26, 2011

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinomaTina Cascone, Matthew H Herynk, Li Xu, et al.

Cancer Research|July 5, 2011

Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent PhenotypeMonique B Nilsson, Jacqulyne Robichaux, Matthew H Herynk, et al.

Pageof 5